StonvexLoading…
StonvexStonvexStonvexCore line items from RRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.01B | $1.94B | $1.72B | $1.66B |
Operating Income | $597.43M | $568.69M | $558.69M | $561.30M |
Net Income | $188.07M | $154.05M | $176.00M | $205.46M |
EPS (Diluted) | $3.12 | $2.53 | $2.94 | $3.36 |
Total Assets | $4.17B | $4.05B | $3.95B | $3.35B |
Total Liabilities | $3.83B | $3.74B | $3.71B | $3.31B |
Cash & Equivalents | $142.47M | $164.38M | $137.59M | $117.29M |
Free Cash Flow OCF − CapEx | $290.50M | $264.39M | $-205.18M | $213.63M |
Shares Outstanding | 102.59M | 103.67M | 103.22M | 104.66M |